Supermax Corporation Berhad Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Supermax Berhad han disminuido a una tasa media anual de -23.7%, mientras que en la industria Medical Equipment los beneficios crecieron en un 8% anualmente. Los ingresos han ido disminuyendo a una tasa media de 17.1% al año.

Información clave

-23.7%

Tasa de crecimiento de los beneficios

-23.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Medical Equipment	12.3%
Tasa de crecimiento de los ingresos	-17.1%
Rentabilidad financiera	-4.1%
Margen neto	-27.2%
Última actualización de beneficios	30 Jun 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Market Still Lacking Some Conviction On Supermax Corporation Berhad (KLSE:SUPERMX)

May 22

Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Debt Sensibly?

Nov 20

Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Too Much Debt?

Apr 17

Bearish: Analysts Just Cut Their Supermax Corporation Berhad (KLSE:SUPERMX) Revenue and EPS estimates

Feb 17

Supermax Corporation Berhad (KLSE:SUPERMX) Could Easily Take On More Debt

Oct 15

Why The 20% Return On Capital At Supermax Corporation Berhad (KLSE:SUPERMX) Should Have Your Attention

Sep 22

These Analysts Just Made A Massive Downgrade To Their Supermax Corporation Berhad (KLSE:SUPERMX) EPS Forecasts

Aug 28

Supermax Corporation Berhad Recorded A 7.1% Miss On Revenue: Analysts Are Revisiting Their Models

Aug 24

Does Supermax Corporation Berhad (KLSE:SUPERMX) Have A Healthy Balance Sheet?

Jul 06

Desglose de ingresos y gastos

Cómo gana y gasta dinero Supermax Corporation Berhad. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

KLSE:SUPERMX Ingresos, gastos y beneficios (MYR Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	646	-176	130
31 Mar 24	689	-46	247
31 Dec 23	722	-85	216
30 Sep 23	751	-149	179
30 Jun 23	821	-141	147
31 Mar 23	899	-123	172
31 Dec 22	1,131	-70	172
30 Sep 22	1,480	86	172
30 Jun 22	2,687	719	172
31 Mar 22	4,262	1,662	190
31 Dec 21	5,792	2,654	190
30 Sep 21	7,267	3,666	190
30 Jun 21	7,164	3,817	190
31 Mar 21	6,218	3,253	136
31 Dec 20	4,728	2,319	136
30 Sep 20	3,114	1,290	136
30 Jun 20	2,132	525	136
31 Mar 20	1,627	140	132
31 Dec 19	1,541	104	132
30 Sep 19	1,541	112	132
30 Jun 19	1,538	123	132
31 Mar 19	1,443	118	128
31 Dec 18	1,409	117	128
30 Sep 18	1,359	115	128
30 Jun 18	1,304	107	128
31 Mar 18	1,288	103	129
31 Dec 17	1,269	89	129
30 Sep 17	1,170	76	129
30 Jun 17	1,127	67	129
30 Jun 16	1,091	94	169
30 Sep 15	1,018	103	93
30 Jun 15	987	92	93
31 Mar 15	995	94	93
31 Dec 14	1,004	96	93
30 Sep 14	862	97	85
30 Jun 14	868	105	85
31 Mar 14	960	114	85
31 Dec 13	1,048	120	85

Ingresos de calidad: SUPERMX actualmente no es rentable.

Margen de beneficios creciente: SUPERMX actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: SUPERMX no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 23.7% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de SUPERMX en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: SUPERMX no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Medical Equipment (-1.4%).

Rentabilidad financiera

Alta ROE: SUPERMX tiene una rentabilidad financiera negativa (-4.1%), ya que actualmente no es rentable.

Supermax Corporation Berhad Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2024 earnings: EPS and revenues miss analyst expectations

Full year 2024 earnings released: RM0.068 loss per share (vs RM0.053 loss in FY 2023)

Third quarter 2024 earnings released: EPS: RM0 (vs RM0.015 loss in 3Q 2023)

Second quarter 2024 earnings released: RM0.017 loss per share (vs RM0.041 loss in 2Q 2023)

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings released: RM0.057 loss per share (vs RM0.27 profit in FY 2022)

Recent updates

Full year 2024 earnings: EPS and revenues miss analyst expectations

Supermax Corporation Berhad, Annual General Meeting, Nov 28, 2024

Full year 2024 earnings released: RM0.068 loss per share (vs RM0.053 loss in FY 2023)

Supermax Corporation Berhad Announces the Appointment of Rozita Binti Abdul Rahman as Independent and Non Executive Chairman of Risk Committee

Third quarter 2024 earnings released: EPS: RM0 (vs RM0.015 loss in 3Q 2023)

Market Still Lacking Some Conviction On Supermax Corporation Berhad (KLSE:SUPERMX)

Supermax Corporation Berhad (KLSE:SUPERMX) entered into a Share Sale Agreement to acquire remaining 33% stake in Supermax Healthcare Canada Inc. from Sylvain Bergeron for CAD 5.5 million.

Supermax Corporation Berhad Announces Resignation of Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee

Supermax Corporation Berhad Announces Audit Committee Changes, Effective May 8, 2024

Second quarter 2024 earnings released: RM0.017 loss per share (vs RM0.041 loss in 2Q 2023)

High number of new directors

Price target increased by 8.3% to RM0.97

Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as Chief Executive Officer, Effective January 2, 2024

Supermax Corporation Bhd Appoints Tan Chee Keong or CK Tan as its Senior Executive Director Effective January 2, 2024

Supermax Corporation Berhad Announces Re-Designation of Tan Chee Keong as Chief Executive Officer from Executive Director, Effective January 2, 2024

Supermax Corporation Berhad Announces Retirement of Miss TAN POH CHAN as Independent and Non Executive Director

Price target increased by 7.8% to RM0.97

Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Debt Sensibly?

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Supermax Corporation Berhad, Annual General Meeting, Dec 08, 2023

U.S. Customs and Border Protection Modifies the Withhold Release Order Issued on October 21, 2021, Against Supermax Corporation Bhd. and Its Wholly Owned Subsidiaries

U.S. Customs and Border Protection Modifies the Withhold Release Order Issued on October 21, 2021, Against Supermax Corporation Bhd. and Its Wholly Owned Subsidiaries

Full year 2023 earnings released: RM0.057 loss per share (vs RM0.27 profit in FY 2022)

Supermax Corporation Berhad Announces Resignation of Wong Wai Foong as Company Secretary

Price target increased by 8.4% to RM0.87

Supermax Corporation Berhad Appoints Tan Poh Chan as Independent and Non Executive Chairman of Risk Committee

Upcoming dividend of RM0.035 per share at 12% yield

Supermax Corporation Berhad Reports Impairment Charges for the Third Quarter Ended March 31, 2023

Third quarter 2023 earnings released: RM0.015 loss per share (vs RM0.005 profit in 3Q 2022)

Is Supermax Corporation Berhad (KLSE:SUPERMX) Using Too Much Debt?

Bearish: Analysts Just Cut Their Supermax Corporation Berhad (KLSE:SUPERMX) Revenue and EPS estimates

Second quarter 2023 earnings released: RM0.041 loss per share (vs RM0.018 profit in 2Q 2022)

Supermax Corporation Berhad Appoints Puan Rozita Binti Abdul Rahman as Member of Nomination and Remuneration Committee, Date of Change 03 Jan 2023

Supermax Corporation Berhad Announces Retirement of RASHID BIN BAKAR as Independent and Non Executive Director

Upcoming dividend of RM0.03 per share

Consensus revenue estimates fall by 13%

First quarter 2023 earnings released: EPS: RM0.002 (vs RM0.25 in 1Q 2022)

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Supermax Corporation Berhad, Annual General Meeting, Dec 08, 2022

Final Dividend Supermax Corporation Berhad Declares Final Single-Tier Dividend of the Financial Year Ended 30 June 2022, Payable on January 18, 2023

Supermax Corporation Berhad Announces Redesignation of Dato' Ting Heng Peng from Independent Director to Non-Independent Director

Supermax Corporation Berhad (KLSE:SUPERMX) Could Easily Take On More Debt

Price target decreased to RM0.67

Why The 20% Return On Capital At Supermax Corporation Berhad (KLSE:SUPERMX) Should Have Your Attention

Supermax Corporation Berhad(KLSE:SUPERMX) dropped from FTSE All-World Index (USD)

These Analysts Just Made A Massive Downgrade To Their Supermax Corporation Berhad (KLSE:SUPERMX) EPS Forecasts

Supermax Corporation Berhad Recorded A 7.1% Miss On Revenue: Analysts Are Revisiting Their Models

Supermax Corporation Berhad Proposes Final Single-Tier Dividend of the Financial Year Ended 30 June 2022

Price target decreased to RM0.73

Supermax Corporation Berhad Announces Resignation of Datuk Seri Dr. HJ. Rashid Bin HJ. Bakar as Chairman of Risk Committee

Does Supermax Corporation Berhad (KLSE:SUPERMX) Have A Healthy Balance Sheet?

Now 20% undervalued after recent price drop

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado